Development and validation of a motor function classification in patients with neuromuscular disease: The NM-Score

Vuillerot, Carole; Rippert, Pascal; Roche, Sylvain; Bérard, C.; Margirier, F.; Lattre, Capucine de; Poirot, I.; Berruyer, A.; Tiffreau, V.; Fournier-Mehouas, M.; Bouhour, Françoise; Urtizberea, Jon Andoni; Renders, Anne; Écochard, René; Flem, A. Le; Barrière, Aurélie; Rouyer, A.; Fontaine, S.; Vadot, J P; Pupat, E. Luc; Chartier, Y.; Vincent-Genod, Dominique; Girardot, F.; Manel, Véronique; Aubert, F; Rode, Gilles; Denis, D.; Germa, Virginie; Quijano, Sergio; Pelligrini, N.; D’Anjou, M.-C.; Féasson, Léonard; Chabrier, Stéphane; Furby, Alain; Goyet, C.; Delmas, Marie-Christine; Campech, M.; Robert, Ferdinand; Hovart, H.; Cuisset, J.; Badoil, I.; Fafin, Coraline; Tanant, Véronique; Sacconi, Sabrina; Gayraud, Jérôme; Carpentier, Antoine F.; Vanderschueren, Steven; Bourdeauducq, I.; Salicio-Castillo, D.; Cobo, Ana-Maria; Commare, Marie-Christine; Farigoule, Vincent; Huzar, C.; Berger, B.; Humbertclaude, Véronique; Rumeau, F.; Viehweger, Elke; Payet-Laury, C.; Pénisson-Besnier, I.; Kinet, Virginie; Laridant, D.; Spehrs-Ciaffi, V.; Bassez, Guillaume; Goemans, N.; Pichancourt, D.; Jezequel, L.; Vedrenne, N.

doi:10.1016/j.rehab.2013.10.002

Cited by 8 publications

(10 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13 Its reproducibility was considered good. For D1, D2, and D3, the levels of agreement between raters were 82.9%, 78.1%, and 75.6%, and the kappa coefficients were .77, .69, and .64, respectively.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

English Cross-Cultural Translation and Validation of the Neuromuscular Score: A System for Motor Function Classification in Patients With Neuromuscular Diseases

Vuillerot

Meilleur

Jain

et al. 2014

Archives of Physical Medicine and Rehabilitation

View full text Add to dashboard Cite

Objective To develop and validate an English version of the Neuromuscular (NM)-Score, a classification for patients with NM diseases in each of the 3 motor function domains: D1, standing and transfers; D2, axial and proximal motor function; and D3, distal motor function. Design Validation survey. Setting Patients seen at a medical research center between June and September 2013. Participants Consecutive patients (N = 42) aged 5 to 19 years with a confirmed or suspected diagnosis of congenital muscular dystrophy. Interventions Not applicable. Main Outcome Measures An English version of the NM-Score was developed by a 9-person expert panel that assessed its content validity and semantic equivalence. Its concurrent validity was tested against criterion standards (Brooke Scale, Motor Function Measure [MFM], activity limitations for patients with upper and/or lower limb impairments [ACTIVLIM], Jebsen Test, and myometry measurements). Informant agreement between patient/caregiver (P/C)-reported and medical doctor (MD)-reported NM scores was measured by weighted kappa. Results Significant correlation coefficients were found between NM scores and criterion standards. The highest correlations were found between NM-score D1 and MFM score D1 (ρ = −.944, P<.0001), ACTIVLIM (ρ = −.895, P<.0001), and hip abduction strength by myometry (ρ = −.811, P<.0001). Informant agreement between P/C-reported and MD-reported NM scores was high for D1 (κ = .801; 95% confidence interval [CI], .701–.914) but moderate for D2 (κ = .592; 95% CI, .412–.773) and D3 (κ = .485; 95% CI, .290–.680). Correlation coefficients between the NM scores and the criterion standards did not significantly differ between P/C-reported and MD-reported NM scores. Conclusions Patients and physicians completed the English NM-Score easily and accurately. The English version is a reliable and valid instrument that can be used in clinical practice and research to describe the functional abilities of patients with NM diseases.

show abstract

Section: Methodsmentioning

confidence: 99%

“…13 Based on a statement by the World Health Organization about the potential influence of personal and environmental factors on the way patients with NMDs manifest their mobility capacities, 9 the NM-Score focuses on motor function performance under typical current circumstances, not under controlled test conditions.…”

mentioning

confidence: 99%

English Cross-Cultural Translation and Validation of the Neuromuscular Score: A System for Motor Function Classification in Patients With Neuromuscular Diseases

Vuillerot

Meilleur

Jain

et al. 2014

Archives of Physical Medicine and Rehabilitation

View full text Add to dashboard Cite

show abstract

“…Actually, although our sample size was smaller (n = 51) and the patients were younger (7-21 years) than those of Berard et al 's study (10), the variety of the NMDs was similar as they consisted of DMD (n = 25), myopathy (n = 9), SMA (n = 5), BMD (n = 5), polyneuropathy (n = 5), and Friedreich ataxia (n = 5) patients. They found that "agreement coefficients for interrater reliability were excellent for nine items, good for 20 (19) have also reported in a study in 448 patients with genetic neuromuscular diseases that the MFM-32 was a reliable, reproducible, and valuable outcome measure for clinical practice and research, since it was able to describe the physical status of patients and formulate the uniform patient groups according to motor function.…”

Section: Discussionmentioning

confidence: 85%

Turkish version of the Motor Function Measure Scale (MFM-32) forneuromuscular diseases: a cross-cultural adaptation, reliability, and validity study

İnal¹,

Ela²,

Tarakçı³

et al. 2017

Turk J Med Sci

View full text Add to dashboard Cite

“…The validated Motor Function Measure scale, items 13 to 23, was used to evaluate the sitting position, function of the arms, neck and head control in the patient group. 26,27 Masticatory Training At the start of the masticatory training all participants received a box including 3 chewing gum packs, stopwatch and a diary. All participants followed the same program which was written on the back side of the box and on the chewing gum wrappers.…”

Section: Physical Abilitiesmentioning

confidence: 99%

“…In the healthy subjects, a significant difference could be demonstrated between measurements at T 1 or T 2 regarding the protrusion, albeit within the smallest detectable change of 2 mm (Table 2). 27 …”

Section: Clinical Examination Of the Masticatory Systemmentioning

confidence: 99%

Fighting Against Disuse of the Masticatory System in Duchenne Muscular Dystrophy

et al. 2015

View full text Add to dashboard Cite

Duchenne muscular dystrophy patients report masticatory problems. The aim was to determine the efficacy of mastication training in Duchenne muscular dystrophy using chewing gum for 4 weeks. In all, 17 patients and 17 healthy age-matched males participated. The masticatory performance was assessed using a mixing ability test and measuring anterior bite force before, shortly after and 1 month after the training. In the patient group the masticatory performance improved and remained after 1-month follow-up, no significant changes in anterior maximum bite force was observed after mastication training. In the healthy subject the bite force increased and remained at the 1-month follow-up; no significant differences in masticatory performance were observed. Mastication training by using sugar-free chewing gum in Duchenne muscular dystrophy patients improved their masticatory performance. Since bite force did not improve, the working mechanism of the improvement in chewing may relate to changes of the neuromuscular function and coordination, resulting in improvement of skills in performing mastication.

show abstract

Development and validation of a motor function classification in patients with neuromuscular disease: The NM-Score

Abstract: The NM-Score is a reliable, reproducible outcome measure with value in clinical practice and in clinical research for the description of patients and the constitution of uniform patient groups (in terms of motor function).

Cited by 8 publications

References 14 publications

English Cross-Cultural Translation and Validation of the Neuromuscular Score: A System for Motor Function Classification in Patients With Neuromuscular Diseases

English Cross-Cultural Translation and Validation of the Neuromuscular Score: A System for Motor Function Classification in Patients With Neuromuscular Diseases

Turkish version of the Motor Function Measure Scale (MFM-32) forneuromuscular diseases: a cross-cultural adaptation, reliability, and validity study

Fighting Against Disuse of the Masticatory System in Duchenne Muscular Dystrophy

Contact Info

Product

Resources

About